Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals
  • Print
  • Share
  • E-mail
-
Generic Name: capsaicin
Trade Name: Qutenza
Date Designated: 05/22/2009
Orphan Designation: Management of neuropathic pain in patients with postherpetic neuralgia
Orphan Designation Status: Designated/Approved
Averitas Pharma, Inc.
360 Mount Kemble Avenue
Morristown, New Jersey 07960
United States

The sponsor address listed is the last reported by the sponsor to OOPD.

Marketing approved:

1 Generic Name: capsaicin
Trade Name: Qutenza
Marketing Approval Date: 11/16/2009
Approved Labeled Indication: Management of neuropathic pain associated with postherpetic neuralgia
Exclusivity End Date: 11/16/2016 
Exclusivity Protected Indication* :  
*Exclusivity Protected Indications are shown for approvals from 01/01/2013 to the present.
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-
-